Abstract
During transplant surgery, clot formation resulting in life-threatening thromboembolic phenomena or graft loss may be a consequence unless close monitoring of coagulation and anticoagulation treatment is instituted in a timely manner. Three cases with a hypercoagulable state, as determined by thrombelastography at the time of surgery, but whose hypercoagulation was gradually attenuated with hydroxyethyl starch infusion during transplantation, are presented.
Copyright © 2011 Elsevier Inc. All rights reserved.
MeSH terms
-
Adult
-
Diabetes Mellitus, Type 1 / surgery
-
Humans
-
Hydroxyethyl Starch Derivatives / administration & dosage
-
Hydroxyethyl Starch Derivatives / therapeutic use*
-
Infusions, Intravenous
-
Intestines / transplantation
-
Intraoperative Complications / drug therapy*
-
Kidney Failure, Chronic / surgery
-
Kidney Transplantation / adverse effects
-
Male
-
Middle Aged
-
Monitoring, Intraoperative
-
Organ Transplantation / adverse effects*
-
Pancreas Transplantation / adverse effects
-
Plasma Substitutes / administration & dosage
-
Plasma Substitutes / therapeutic use*
-
Thrombelastography
-
Thrombophilia / drug therapy*
Substances
-
Hydroxyethyl Starch Derivatives
-
Plasma Substitutes